EHNA

From Wikipedia, the free encyclopedia
Jump to: navigation, search
EHNA
EHNA.svg
Systematic (IUPAC) name
3-(6-aminopurin-9-yl)nonan-2-ol hydrochloride
Clinical data
Legal status
?
Identifiers
CAS number 59262-86-1
ATC code ?
PubChem CID 359137
ChEMBL CHEMBL50378 YesY
Chemical data
Formula C14H24ClN5O 
Mol. mass 313.826 g/mol
 YesY (what is this?)  (verify)

EHNA (erythro-9-(2-hydroxy-3-nonyl)adenine) is a potent adenosine deaminase inhibitor,[1] which also acts as a phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type 2 (PDE2).[2][3]

References[edit]

  1. ^ "Sigma Aldrich". Retrieved 16 January 2013. 
  2. ^ Podzuweit, T; Nennstiel, P; Muller, A (1995). "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". Cell Signal 7 (7): 733–8. doi:10.1016/0898-6568(95)00042-N. PMID 8519602. 
  3. ^ Méry, PF; Pavoine, C; Pecker, F; Fischmeister, R (1995). "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes". Mol Pharmacol 48 (1): 121–130. PMID 7623766.